Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van de Loo

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Herz|January 24, 1998
[Batista partial left ventricular resection in terminal heart failure]F Beyersdorf, A van de Loo
Clinics in Sports Medicine|July 1, 1995
The young female athleteD A Van de Loo, M D Johnson
Kidney International. Supplement|November 24, 1999
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysisK G Fischer, A van de Loo, J Böhler
The American Journal of Cardiology|December 1, 1994
Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjectsA van de Loo, W Arendts, S H Hohnloser
Zeitschrift Fur Kardiologie|December 1, 1994
[Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects]A van de Loo, T Klingenheben, S H Hohnloser
Zeitschrift Fur Kardiologie|January 1, 1994
[Atrial fibrillation and the autonomic nervous system]S H Hohnloser, A van de Loo, T Klingenheben
Journal of the American College of Cardiology|October 1, 1995
Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidineS H Hohnloser, A van de Loo, F Baedeker
Arthritis Research & Therapy|November 12, 2009
Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?Fons A van de Loo, Wim B van den Berg
Annals of the Rheumatic Diseases|April 1, 1990
Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammationA A van de Loo, W B van den Berg
European Heart Journal|March 21, 1998
Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCAA van de Loo, M Nauck, E Noory, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Herz|January 24, 1998
[Batista partial left ventricular resection in terminal heart failure]F Beyersdorf, A van de Loo
Clinics in Sports Medicine|July 1, 1995
The young female athleteD A Van de Loo, M D Johnson
Kidney International. Supplement|November 24, 1999
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysisK G Fischer, A van de Loo, J Böhler
The American Journal of Cardiology|December 1, 1994
Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjectsA van de Loo, W Arendts, S H Hohnloser
Zeitschrift Fur Kardiologie|December 1, 1994
[Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects]A van de Loo, T Klingenheben, S H Hohnloser
Zeitschrift Fur Kardiologie|January 1, 1994
[Atrial fibrillation and the autonomic nervous system]S H Hohnloser, A van de Loo, T Klingenheben
Journal of the American College of Cardiology|October 1, 1995
Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidineS H Hohnloser, A van de Loo, F Baedeker
Arthritis Research & Therapy|November 12, 2009
Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?Fons A van de Loo, Wim B van den Berg
Annals of the Rheumatic Diseases|April 1, 1990
Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammationA A van de Loo, W B van den Berg
European Heart Journal|March 21, 1998
Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCAA van de Loo, M Nauck, E Noory, et al.
Pageof 10